NO20072285L - S-mirtazapin for behandling av hetetokter - Google Patents
S-mirtazapin for behandling av hetetokterInfo
- Publication number
- NO20072285L NO20072285L NO20072285A NO20072285A NO20072285L NO 20072285 L NO20072285 L NO 20072285L NO 20072285 A NO20072285 A NO 20072285A NO 20072285 A NO20072285 A NO 20072285A NO 20072285 L NO20072285 L NO 20072285L
- Authority
- NO
- Norway
- Prior art keywords
- mirtazapine
- treatment
- hot flashes
- flashes
- hot
- Prior art date
Links
- 208000033830 Hot Flashes Diseases 0.000 title abstract 3
- 206010060800 Hot flush Diseases 0.000 title abstract 3
- RONZAEMNMFQXRA-MRXNPFEDSA-N esmirtazapine Chemical compound C1C2=CC=CN=C2N2CCN(C)C[C@@H]2C2=CC=CC=C21 RONZAEMNMFQXRA-MRXNPFEDSA-N 0.000 title abstract 3
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04105778 | 2004-11-15 | ||
| PCT/EP2005/055947 WO2006051111A1 (en) | 2004-11-15 | 2005-11-14 | S-mirtazapine for the treatment of hot flush |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20072285L true NO20072285L (no) | 2007-06-13 |
Family
ID=34929859
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20072285A NO20072285L (no) | 2004-11-15 | 2007-04-30 | S-mirtazapin for behandling av hetetokter |
Country Status (30)
| Country | Link |
|---|---|
| US (4) | US20070265245A1 (enExample) |
| EP (1) | EP1814555B1 (enExample) |
| JP (1) | JP2008519810A (enExample) |
| KR (1) | KR20070085470A (enExample) |
| CN (2) | CN101056641A (enExample) |
| AR (1) | AR053780A1 (enExample) |
| AT (1) | ATE439843T1 (enExample) |
| AU (1) | AU2005303778B2 (enExample) |
| BR (1) | BRPI0517818A2 (enExample) |
| CA (1) | CA2587283C (enExample) |
| CY (1) | CY1110538T1 (enExample) |
| DE (1) | DE602005016141D1 (enExample) |
| DK (1) | DK1814555T3 (enExample) |
| ES (1) | ES2329815T3 (enExample) |
| HR (1) | HRP20090513T1 (enExample) |
| IL (1) | IL182767A (enExample) |
| MX (1) | MX2007005827A (enExample) |
| MY (1) | MY144089A (enExample) |
| NO (1) | NO20072285L (enExample) |
| NZ (1) | NZ554858A (enExample) |
| PE (1) | PE20061051A1 (enExample) |
| PL (1) | PL1814555T3 (enExample) |
| PT (1) | PT1814555E (enExample) |
| RS (1) | RS51138B (enExample) |
| RU (1) | RU2396957C2 (enExample) |
| SI (1) | SI1814555T1 (enExample) |
| TW (1) | TW200631584A (enExample) |
| UA (1) | UA88655C2 (enExample) |
| WO (1) | WO2006051111A1 (enExample) |
| ZA (1) | ZA200703884B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007002174A2 (en) * | 2005-06-27 | 2007-01-04 | N.V. Organon. | A method of treatment of hormone depletion induced vasomotor symptoms |
| US20070129611A1 (en) * | 2005-12-06 | 2007-06-07 | University Of North Texas Health Science Center At Fort Worth | System, Method and Apparatus for Assessing Menopausal or Post-Hysterectomy Symptoms |
| EP1993556A1 (en) * | 2006-03-06 | 2008-11-26 | N.V. Organon | An improved method of weaning from hormonal treatment of hormone depletion induced vasomotor symptoms |
| AU2007324467A1 (en) * | 2006-11-22 | 2008-05-29 | N.V. Organon | Vaginal delivery system for mirtazapine |
| US7645750B2 (en) * | 2006-12-13 | 2010-01-12 | Yung Shin Pharmaceutical Ind. Co., Ltd. | Method of treating symptoms of hormonal variations |
| JP2009018992A (ja) | 2007-07-10 | 2009-01-29 | Sumitomo Chemical Co Ltd | 光学活性ミルタザピンの製造方法 |
| US8420624B2 (en) | 2007-12-04 | 2013-04-16 | Yung Shin Pharm. Ind. Co., Ltd. | Methods for treating or preventing symptoms of hormonal variations |
| JP6876003B2 (ja) | 2015-02-27 | 2021-05-26 | デクラ リミテッド | イヌ及びネコにおける、食欲の刺激、体重減少の管理、及び拒食症の処置 |
| KR102608479B1 (ko) * | 2017-05-25 | 2023-12-01 | 글리테크 엘엘씨. | Nmdar 길항제-반응성 신경정신 질환을 위한 병용 요법 |
| WO2021167579A1 (ru) | 2020-02-19 | 2021-08-26 | Иван УЛИНИЧ | Универсальное устройство для тепловой обработки пищевых продуктов |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL189199C (nl) * | 1975-04-05 | 1993-02-01 | Akzo Nv | Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten. |
| US4515792A (en) * | 1982-09-30 | 1985-05-07 | Ciba-Geigy Corporation | Tetracyclic heterocycles and antidepressant compositions thereof |
| JPH1187727A (ja) * | 1997-09-12 | 1999-03-30 | Mitsubishi Electric Corp | 半導体装置 |
| ES2212550T3 (es) * | 1998-04-02 | 2004-07-16 | Akzo Nobel N.V. | Solucion oral liquida que comprende el antidepresor mirtazapina. |
| RU2195951C1 (ru) * | 2001-08-20 | 2003-01-10 | Общество с ограниченной ответственностью "Лаборатория "Ирис" | Средство для лечения климактерических расстройств |
-
2005
- 2005-11-10 TW TW094139442A patent/TW200631584A/zh unknown
- 2005-11-14 PE PE2005001334A patent/PE20061051A1/es not_active Application Discontinuation
- 2005-11-14 EP EP05808013A patent/EP1814555B1/en not_active Expired - Lifetime
- 2005-11-14 PL PL05808013T patent/PL1814555T3/pl unknown
- 2005-11-14 RS RSP-2009/0504A patent/RS51138B/sr unknown
- 2005-11-14 BR BRPI0517818-5A patent/BRPI0517818A2/pt not_active IP Right Cessation
- 2005-11-14 AR ARP050104768A patent/AR053780A1/es unknown
- 2005-11-14 JP JP2007540655A patent/JP2008519810A/ja active Pending
- 2005-11-14 PT PT05808013T patent/PT1814555E/pt unknown
- 2005-11-14 AU AU2005303778A patent/AU2005303778B2/en not_active Expired
- 2005-11-14 DK DK05808013T patent/DK1814555T3/da active
- 2005-11-14 AT AT05808013T patent/ATE439843T1/de active
- 2005-11-14 WO PCT/EP2005/055947 patent/WO2006051111A1/en not_active Ceased
- 2005-11-14 KR KR1020077011981A patent/KR20070085470A/ko not_active Ceased
- 2005-11-14 CN CNA200580038949XA patent/CN101056641A/zh active Pending
- 2005-11-14 CN CN2012102639294A patent/CN102772414A/zh active Pending
- 2005-11-14 MY MYPI20055321A patent/MY144089A/en unknown
- 2005-11-14 CA CA2587283A patent/CA2587283C/en not_active Expired - Fee Related
- 2005-11-14 MX MX2007005827A patent/MX2007005827A/es active IP Right Grant
- 2005-11-14 DE DE602005016141T patent/DE602005016141D1/de not_active Expired - Lifetime
- 2005-11-14 RU RU2007122391/14A patent/RU2396957C2/ru not_active IP Right Cessation
- 2005-11-14 UA UAA200705135A patent/UA88655C2/ru unknown
- 2005-11-14 NZ NZ554858A patent/NZ554858A/en not_active IP Right Cessation
- 2005-11-14 ES ES05808013T patent/ES2329815T3/es not_active Expired - Lifetime
- 2005-11-14 SI SI200530802T patent/SI1814555T1/sl unknown
- 2005-11-14 HR HR20090513T patent/HRP20090513T1/xx unknown
- 2005-11-14 US US11/667,579 patent/US20070265245A1/en not_active Abandoned
-
2007
- 2007-04-23 IL IL182767A patent/IL182767A/en not_active IP Right Cessation
- 2007-04-30 NO NO20072285A patent/NO20072285L/no not_active Application Discontinuation
- 2007-05-14 ZA ZA200703884A patent/ZA200703884B/xx unknown
-
2009
- 2009-10-12 CY CY20091101044T patent/CY1110538T1/el unknown
-
2010
- 2010-07-01 US US12/828,720 patent/US20100267694A1/en not_active Abandoned
-
2012
- 2012-08-09 US US13/570,481 patent/US20120302552A1/en not_active Abandoned
-
2013
- 2013-04-05 US US13/857,445 patent/US20130225559A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20076206L (no) | Kombinasjon av PDE4 inhibitor romflumilast og et tetrahydrobioterin-derivativ | |
| DK1853271T3 (da) | Fremgangsmåde og præparat til behandling af perifere vaskulære sygdomme | |
| HUS1500058I1 (hu) | Benzoxazint tartalmazó gyógyszer-kombináció légúti betegségek kezelésére | |
| PL2878297T3 (pl) | Leki do leczenia lub zapobiegania chorobom zwłóknieniowym | |
| IL179515A0 (en) | Method of administering and using vegf inhibitors for the treatment of human cancer | |
| NO20052760D0 (no) | Fremgangsmate for behandling av kreft og beslektede fremgangsmater. | |
| DE602005014127D1 (de) | Medizinische vorrichtung und herstellungsverfahren dafür | |
| AP2327A (en) | Quinoline derivatives for the treatment of latent tuberculosis. | |
| NO20083002L (no) | Fremgangsmate for anvendelse av CD40-bindende forbindelser | |
| DK1644021T3 (da) | Fremgangsmåder og sammensætninger til behandlingen af gastrointestinale sygdomme | |
| NO20070782L (no) | Tetrapeptidanaloger. | |
| DK1663978T3 (da) | Fluorsubstitueret omega-carboxyaryl-diphenylurinstof til behandling og forebyggelse af sygdomme og lidelser | |
| ATE474617T1 (de) | Medizinproduktsysteme | |
| EP1799154A4 (en) | STENT AND METHOD FOR PRODUCING THE STENT | |
| IL177490A0 (en) | Methods for the treatment of tinnitus induced by cochlear excitotoxicity | |
| DE60322451D1 (de) | 4-Tetrazolyl-4-Phenylpiperidinderivate zur Schmerzbehandlung | |
| DK1817282T3 (da) | Til behandling af respiratoriske sygdomme egnede phenoxy derivater | |
| CY1110538T1 (el) | S-μιρταζαπινη για τη θεραπεια των εξαψεων | |
| IS7699A (is) | Afleiður af díoxan-2-alkýl karbamötum, framleiðslu aðferð þeirra og notkun við meðferð sjúkdóma | |
| NO20050569D0 (no) | Fremgangsmate for behandling av alvorlig hjertesvikt og medikament for dette | |
| NO20054494L (no) | Peptidvektorer | |
| DK1487828T3 (da) | Morpholinyl-urea-derivater til anvendelse til behandling af inflammatoriske sygdomme | |
| EP1827478A4 (en) | METHODS OF TREATING JOINED OR SICK JOINTS | |
| DK1848415T3 (da) | Kombinationsterapi med glatirameracetat og rasagilin til behandling af multipel sklerose | |
| DK1670482T4 (da) | Anvendelse af ciclesonid til behandlingen af respiratoriske sygdomme |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |